Pharma Stocks to Buy for Big Dividends

When investors think of pharmaceutical stocks, they tend to see them as growth opportunities, capitalizing on a collection of novel, game-changing, and often life-saving drugs. Rarely does a steady stream of income factor in to the decision to buy a particular drugmaker’s stock.

But the fact is, many of these companies dole out sizable dividends on a regular basis. Investors seeking cash flow as much as capital growth from the pharmaceutical industry should consider one or two of these five strong dividend stocks from that space. Some of these names might even surprise you: AstraZeneca (AZN) still pays dividends at a rate of 4.9%. Merck (MRK) as the pharmaceutical stock that paid out 3.6% of the stock’s current price in the form of dividends over the past twelve months. Eli Lilly (LLY) out, and it’s too soon to assume its 3.9% dividend yield is going to evaporate. GlaxoSmithKline (GSK) offers the second-biggest payout among the traditional pharmaceutical companies. PDL BioPharma (PDLI) boasts the biggest payout with a whopping yield of 7.4%.

Source: InvestorPlace

Related Articles:
- Investments That Pay Monthly Dividends
- 12 Higher Yielding Stocks With A Low Dividend Payout Ratio
- Early Warning Signs of a Dividend Cut
- Income Annuities vs. Dividend Stocks
- 7 Tech Stocks With A History of Growing Their Dividends